Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention Coherence Neuro, the most common co-covered peer. Each story carries 7 original sources on average, compared with 3.6 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Graphenicalab
Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention Coherence Neuro, the most common co-covered peer. Each story carries 7 original sources on average, compared with 3.6 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 5.8 in the same window. We currently track 1 Healthcare story that mention Graphenicalab, all published on March 6, 2026.
Stories tracked
1
Sources per story
7
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Graphenicalab. Shared-story counts are live from our verified record — not editorial picks.
The 2026 Bioelectronic Medicine Forum in New York City will feature a keynote from the founder of Iota Biosciences, a leader in miniaturized neural implants. The event highlights a growing international ecosystem of neurotech startups, including Coherence Neuro and Spiro Medical, focused on 'electroceuticals.'